Rare diseases
Investigational molecules
Locations
Breite Straße 20b, 13187 Berlin, Germany
Clinical Studies Pankow in Berlin, Germany specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Asthma, and other specialisations. This site conducts important research.
The medical center is at the forefront of respiratory medicine, focusing on innovative treatments for Chronic Obstructive Pulmonary Disease (COPD). Through cutting-edge research, the center aims to improve patient outcomes and quality of life.
By evaluating the effects of astegolimab compared to placebo, the center contributes significantly to understanding and managing moderate and severe acute exacerbations of COPD, enhancing therapeutic strategies over a 52-week treatment period.
Clinical trials currently enrolling participants at this site.
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
GermanyStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
GermanyAsthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate
GermanyStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
GermanyStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
